(Circulation. 1997;95:1363-1365.)
© 1997 American Heart Association, Inc.
Articles |
Plasma Adenosine Levels Increase in Patients With Chronic Heart Failure
From The First Department of Medicine, Osaka University School of Medicine, Suita, Japan.
Background Adenosine is believed to be cardioprotective; however, it has not been elucidated whether the plasma adenosine level is increased in chronic heart failure.
Methods and Results Seventy-one patients attending a specialized heart failure clinic during a 6-month period were grouped according to the cause of chronic heart failure and the New York Heart Association function class. There were 40 patients with chronic heart failure due to ischemic heart diseases and 31 patients with valvular heart diseases and dilated cardiomyopathy. Control subjects consisted of 64 healthy laboratory staff members and patients without chronic heart failure. We found that the plasma adenosine levels were increased in patients with ischemic and nonischemic heart failure (218±23 and 211±21 nmol/L, respectively, versus 62±3 nmol/L for healthy subjects) and that the extent of increases in adenosine levels correlated well with the severity of chronic heart failure.
Conclusions We conclude that adenosine levels in the systemic blood increase in patients in ischemic and nonischemic chronic heart failure. Because adenosine counteracts catecholamine-, renin-angiotensin–, and cytokine-induced cellular injury, increased adenosine levels may be endogenous compensatory mechanisms for heart failure.
Key Words: norepinephrine • heart failure • enzymes • adenosine
This article has been cited by other articles:
 |
|
 |
|
  F Franceschi, J-C Deharo, R Giorgi, Y By, C Monserrat, J Condo, Z Ibrahim, A Saadjian, and R Guieu Peripheral plasma adenosine release in patients with chronic heart failure Heart, April 1, 2009; 95(8): 651 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Velot, B. Haas, F. Leonard, I. Ernens, M. Rolland-Turner, C. Schwartz, D. Longrois, Y. Devaux, and D. R. Wagner Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages Cardiovasc Res, November 1, 2008; 80(2): 246 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vallon, C. Miracle, and S. Thomson Adenosine and kidney function: Potential implications in patients with heart failure Eur J Heart Fail, February 1, 2008; 10(2): 176 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pevernagie, J. P. Janssens, W. De Backer, M. Elliott, J. Pepperell, and S. Andreas Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep Eur. Respir. Rev., December 1, 2007; 16(106): 115 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Givertz, B. M. Massie, T. K. Fields, L. L. Pearson, H. C. Dittrich, and on behalf of the CKI-201 and CKI-202 Investigators The Effects of KW-3902, an Adenosine A1-Receptor Antagonist,on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance J. Am. Coll. Cardiol., October 16, 2007; 50(16): 1551 - 1560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Traverse, Y. Chen, M. Hou, Y. Li, and R. J. Bache Effect of K+ATP Channel and Adenosine Receptor Blockade During Rest and Exercise in Congestive Heart Failure Circ. Res., June 8, 2007; 100(11): 1643 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Funakoshi, L. C. Zacharia, Z. Tang, J. Zhang, L. L. Lee, J. C. Good, D. E. Herrmann, Y. Higuchi, W. J. Koch, E. K. Jackson, et al. A1 Adenosine Receptor Upregulation Accompanies Decreasing Myocardial Adenosine Levels in Mice With Left Ventricular Dysfunction Circulation, May 1, 2007; 115(17): 2307 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wakeno, T. Minamino, O. Seguchi, H. Okazaki, O. Tsukamoto, K.-i. Okada, A. Hirata, M. Fujita, H. Asanuma, J. Kim, et al. Long-Term Stimulation of Adenosine A2b Receptors Begun After Myocardial Infarction Prevents Cardiac Remodeling in Rats Circulation, October 31, 2006; 114(18): 1923 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ernens, D. Rouy, E. Velot, Y. Devaux, and D. R. Wagner Adenosine Inhibits Matrix Metalloproteinase-9 Secretion By Neutrophils: Implication of A2a Receptor and cAMP/PKA/Ca2+ Pathway Circ. Res., September 15, 2006; 99(6): 590 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. T. Gan, V. Rajapurohitam, J. V. Haist, P. Chidiac, M. A. Cook, and M. Karmazyn Inhibition of Phenylephrine-Induced Cardiomyocyte Hypertrophy by Activation of Multiple Adenosine Receptor Subtypes J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 27 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vanderheyden, J. Bartunek, S. Verstreken, L. Mortier, M. Goethals, and B. de Bruyne Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlations Eur J Echocardiogr, January 1, 2005; 6(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, A. N. Sinoway, Z. Gao, M. D. Maile, M. Pu, and L. I. Sinoway Muscle Mechanoreflex and Metaboreflex Responses After Myocardial Infarction in Rats Circulation, November 9, 2004; 110(19): 3049 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Andreas, H. Reiter, L. Luthje, A. Delekat, R. W. Grunewald, G. Hasenfuss, and V. K. Somers Differential Effects of Theophylline on Sympathetic Excitation, Hemodynamics, and Breathing in Congestive Heart Failure Circulation, October 12, 2004; 110(15): 2157 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Feldman The emerging role of pharmacogenomics in the treatment of patients with heart failure Ann. Thorac. Surg., December 1, 2003; 76(6): S2246 - 2253. [Full Text] [PDF]
|
|
|
|
|
|
Y. Liao, S. Takashima, Y. Asano, M. Asakura, A. Ogai, Y. Shintani, T. Minamino, H. Asanuma, S. Sanada, J. Kim, et al. Activation of Adenosine A1 Receptor Attenuates Cardiac Hypertrophy and Prevents Heart Failure in Murine Left Ventricular Pressure-Overload Model Circ. Res., October 17, 2003; 93(8): 759 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gottlieb, D. C. Brater, I. Thomas, E. Havranek, R. Bourge, S. Goldman, F. Dyer, M. Gomez, D. Bennett, B. Ticho, et al. BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy Circulation, March 19, 2002; 105(11): 1348 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Saito, K. Maehara, K. Tamagawa, Y. Oikawa, T. Niitsuma, S.-I. Saitoh, and Y. Maruyama Alterations of endothelium-dependent and -independent regulation of coronary blood flow during heart failure Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H80 - H86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Notarius, D. J. Atchison, G. A. Rongen, and J. S. Floras Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1312 - H1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Meyer, E. S. Chung, S. Perlini, G. R. Norton, A. J. Woodiwiss, M. Lorbar, R. A. Fenton, and J. G. Dobson Jr Antiadrenergic Effects of Adenosine in Pressure Overload Hypertrophy Hypertension, March 1, 2001; 37(3): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nagata, C. Communal, C. C. Lim, M. Jain, T. M. Suter, F. R. Eberli, N. Satoh, W. S. Colucci, C. S. Apstein, and R. Liao Altered beta -adrenergic signal transduction in nonfailing hypertrophied myocytes from Dahl salt-sensitive rats Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2502 - H2508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Wellner-Kienitz, K. Bender, T. Meyer, M. Bunemann, and L. Pott Overexpressed A1 Adenosine Receptors Reduce Activation of Acetylcholine-Sensitive K+ Current by Native Muscarinic M2 Receptors in Rat Atrial Myocytes Circ. Res., March 31, 2000; 86(6): 643 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gottlieb, S. L. Skettino, A. Wolff, E. Beckman, M. L. Fisher, R. Freudenberger, T. Gladwell, J. Marshall, M. Cines, D. Bennett, et al. Effects of BG9719 (CVT-124), an A1-Adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure J. Am. Coll. Cardiol., January 1, 2000; 35(1): 56 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M Borst, P. Szalai, N. Herzog, W. Kubler, and R. H Strasser Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes Cardiovasc Res, October 1, 1999; 44(1): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Malmsjo, A. Bergdahl, X.-H. Zhao, X.-Y. Sun, T. Hedner, L. Edvinsson, and D. Erlinge Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure Cardiovasc Res, July 1, 1999; 43(1): 200 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Malmsjo, A. Bergdahl, S. Moller, X.-H. Zhao, X.-Y. Sun, T. Hedner, L. Edvinsson, and D. Erlinge Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries Cardiovasc Res, July 1, 1999; 43(1): 219 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Wagner, T. Kubota, V. J. Sanders, C. F. McTiernan, and A. M. Feldman Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2141 - H2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Loh, T. R. Rebbeck, P. D. Mahoney, D. DeNofrio, J. L. Swain, and E. W. Holmes Common Variant in AMPD1 Gene Predicts Improved Clinical Outcome in Patients With Heart Failure Circulation, March 23, 1999; 99(11): 1422 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Auchampach and R. Bolli Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1113 - H1116. [Full Text] [PDF]
|
|
|
|
|
|
U. C. Hoppe, E. Jansen, M. Sudkamp, and D. J. Beuckelmann Hyperpolarization-Activated Inward Current in Ventricular Myocytes From Normal and Failing Human Hearts Circulation, January 13, 1998; 97(1): 55 - 65. [Abstract] [Full Text] [PDF]
|
|